Skip to main content
Clinical Trials/ACTRN12619000447156
ACTRN12619000447156
Not Yet Recruiting
N/A

The effect of bronchodilation and bronchoconstiction on airway closure, low ventilation and distribution of ventilation in COPD and asthma using SPECT.

Woolcock Institute of Medical Research0 sites70 target enrollmentMarch 19, 2019

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Woolcock Institute of Medical Research
Enrollment
70
Status
Not Yet Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 19, 2019
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Willing and able to give written informed consent
  • 2\. Have a physician\-diagnosed COPD or asthma
  • 3\. For asthma only:
  • \- no history of smoking or smoking history of less that 10 pack years
  • 4\. For COPD only:
  • \- history of current or past smoking, with total exposure of greater than 10
  • pack years.
  • \- FEV1/FVC ratio of less the 95th percentile of the normal range (according to subject
  • age, gender and height); AND
  • \- FEV1 less the 95th percentile of the normal range predicted for subject age, gender and

Exclusion Criteria

  • 1\. Significant cardiac disease (ischemic heart disease or arrhythmia) deemed by the investigators or the subject’s treating cardiologist to make it unsafe for the subject to undertake a supervised near\-maximal exercise test.
  • 2\. Documented hypersensitivity to, or intolerance of anti\-cholinergic therapies.
  • 3\. Significant respiratory infection or documented exacerbation of Asthma or COPD within the previous 6 weeks.
  • 4\. Intensive Care Unit admission in the last 12 months.
  • 5\. Other active or chronic respiratory pathologies (for example, interstitial lung disease, asthma, chest wall pathology causing ventilatory restriction).
  • 6\. Past history of lung surgery (including lobectomy or pneumonectomy, but not lung biopsy) or thoracic radiation therapy (excluding isolated mediastinal radiation therapy with no evidence of subsequent pulmonary fibrosis).
  • 7\. Any major comorbidities deemed to impact on respiratory physiology or symptoms, including severe on uncontrolled heart failure, morbid obesity (BMI \>40\), muscular or neurological disorders causing respiratory muscle weakness or dysfunctional swallowing.
  • 8\. History of chronic kidney disease (creatine greater than the upper limit of normal).
  • 9\. Unable to perform lung function testing.
  • 10\. Dependence on domiciliary supplemental oxygen, unable to go without for at least 1 hour.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, Not Recruiting
N/A
Comparison of standard and novel, double-active medications used to expand bronchi in diagnostic test in patients suffering from chronic lung disease (chronic obstructive pulmonary disease COPD and asthma).COPD (chronic obstructive pulmonary disease)Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]
EUCTR2014-002667-15-ATMedizinische Universität Innsbruck, Innere Medizin VI
Active, Not Recruiting
Phase 1
The effect of airway dilation on heart and lung function in adult patients born with ventricular septal heart defectsMedDRA version: 19.1Level: PTClassification code 10047298Term: Ventricular septal defectSystem Organ Class: 10010331 - Congenital, familial and genetic disordersTherapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
EUCTR2015-005507-89-DKDepartment of Cardio-Thoracic and Vascular Surgery, Aarhus University Hospital110
Completed
N/A
The use of bronchodilators in people with recently acquired spinal cord injuryacute spinal cord injury and effects of bronchodilators on spirometry measuresRespiratory - Other respiratory disorders / diseasesRespiratory - AsthmaNeurological - Other neurological disorders
ACTRN12609000828224Royal North Shore Hospital Spinal Research Fund20
Completed
N/A
Additive effects of short-acting bronchodilators in COPD patients who still had dyspnea in their daily lives despite long-acting bronchodilators.Chronic obstructive pulmonary disease
JPRN-UMIN000003192Department of Biomedical Laboratory Sciences, Shinshu University School of Health Sciences.60
Recruiting
N/A
The effect of inhaled bronchodilators on surgery for lung cancer surgery in patients with chronic obstructive lung disease; multicenter studyPrimary lung cancer
JPRN-UMIN000025587Osaka University100